Healthcare and Life Science
From female psychopaths to the future of mental health and dementia treatment: Cambridge Festival reveals latest research
Are there more female psychopaths than we thought? How can a new approach to mental health lead us out of the growing crisis? Could new combinations of repurposed drugs promote ‘brain repair’ in MS? What’s the latest in dementia research and treatment? ...
SPT Labtech and RevoluGen demonstrate fully automated Bead-Based High Molecular Weight DNA Extraction
The collaboration delivers a walk-away solution suitable for high-throughput long-read sequencing in under two hours. ...
Challenges to a dual: What makes a dual-brand approach viable?
Pharmaceutical and biologic therapies are increasingly demonstrating their effectiveness in the treatment of multiple diseases. As the trend of therapies being studied and demonstrating effectiveness across multiple indications accelerates, manufacturers are pursuing different approache...
District Council helps bring lifesaving defibrillators to the community
Lifesaving equipment has been installed in sheltered housing communal rooms across South Cambridgeshire thanks to the District Council securing funding. ...
Bio-Rad launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for cell and gene therapy production
Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digital™ PCR During Cell and Gene Therapy Production ...
New screening tool to explore mechanisms behind cancer, autoimmunity and neurodegeneration
Scientists have developed a new screening tool to uncover how genetic changes affect gene activity and can lead to diseases such as cancer, autoimmunity, neurodegeneration and cardiovascular disease. This new tool enables the investigation of thousands of DNA mutations identified by gen...
2024 Corazon's Charity of the Year
Corazon Health is delighted to announce that EACH (East Anglia's Children's Hospices) has been chosen as their 2024 Charity of The Year, following a selection process that included a vote by employees. The charity supports families and provides care for children and young people with li...
Optibrium launches a metabolism prediction software platform tailored to DMPK scientists
Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery ...
Pioneering cataract test for babies has worldwide potential
Researchers are calling on new parents to back a national study to help prevent the most common cause of preventable childhood blindness, congenital cataracts. ...
Jon Hume joins Cuttsy+Cuttsy as New Commercial Director
Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024. ...